News

A herpes drug discovered in the 60s could be used to weaken the protective surface of an antibiotic-resistant bacteria to make it easier to eliminate by immune cells.

Click chemistry, which recently earned a Nobel Prize, may efficiently deliver radioactive cancer treatments to tumors in dogs while reducing side effects.

A meta-analysis has revealed that the level of inflammatory response before vaccination can predict how well an individual responds to a vaccine.

Researchers have solved the structure of the influenza virus' replication machinery, giving structural insights into new potential drug targets and how the virus adapts to different hosts.

Researchers have used a computer model to successfully simulate a clinical trial evaluating the efficacy of multiple treatments for Alzheimer's disease.

Researchers have uncovered a critical feature that a promising new class of cancer drugs, known as CELMoDs, needs to be effective.

According to research, the risk of stomach bleeding caused by long-term use of aspirin can be reduced with a short course of antibiotics.

The specific mutations to the monkeypox virus that have contributed to the virus becoming more infectious and harder to treat have been identified by a team of researchers.

Researchers have used senescent cells as a "vaccine" that can be used as a prophylaxis and a therapeutic to prime the immune system against cancer cells, which has shown positive results in cancer models.

A study by King’s College London suggests that genetic predisposition for systemic lupus erythematosus (SLE) may be protective against severe COVID-19 infection. The results are published in the journal PLOS Genetics.